Catalyst Health Ventures
Catalyst Health Ventures is a Boston-based venture capital firm managing $225 million that invests in early-stage medical device companies, providing capital and strategic support through clinical development and exit, with 14 exits over 18 years.
- Company typePrivate
- Founded2007
- HeadquartersBoston, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Catalyst Health Ventures does
Catalyst Health Ventures is a Boston-based venture capital firm founded in 2007 that specializes in early-stage investments in medical device companies. The firm manages $225 million in capital under management and has operated continuously for 18 years, evaluating 600-800 companies annually and realizing 14 exits over its history. Its portfolio spans multiple medtech subsectors, including cardiovascular devices (Conformal Medical, acquired by W.L. Gore & Associates in 2025) and women's health (Rejoni, developer of the Juveena Hydrogel System, in which the firm led a $25 million Series B in June 2026).
The firm addresses a structural funding gap in early-stage medtech, an area where much of the broader venture industry has shifted toward later-stage rounds. Catalyst Health Ventures provides portfolio companies with capital, strategic guidance, and access to its network of industry contacts, strategic acquirers, and clinical/regulatory expertise, supporting companies through clinical development, regulatory approval, and eventual exit.
Catalyst Health Ventures generates returns primarily through portfolio company exits via strategic acquisitions by larger medical device companies. The firm does not sell products or services in a traditional sense; its revenue stream is effectively management fees on committed capital plus carried interest on realizations. Deal sourcing relies on industry conferences, network referrals, and the firm's 18-year reputation within the medtech founder and strategic acquirer community. The firm is led by Managing Partners Darshana Zaveri and Joshua Phillips, with David Mackey serving as CFO, and operates with a headcount in the 11-50 range consistent with a boutique venture fund.
Catalyst Health Ventures firmographics
Firmographics- Name
- Catalyst Health Ventures
- Legal name
- Catalyst Health Ventures
- Website
- https://chv.vc
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Catalyst Health Ventures is a Boston-based venture capital firm managing $225 million that invests in early-stage medical device companies, providing capital and strategic support through clinical development and exit, with 14 exits over 18 years.
- Ownership category
- akta.pro rank
Catalyst Health Ventures industry classification
Industry- Product category
- Venture Capital / Healthcare Investment
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Where Catalyst Health Ventures is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Catalyst Health Ventures business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Investment Returns / Capital Gains: Catalyst Health Ventures generates returns through successful exits of portfolio companies. The firm achieves exits via strategic acquisitions by larger medical device companies, as exemplified by the W.L. Gore & Associates acquisition of Conformal Medical.
Marketing channels2 records
Catalyst Health Ventures product offering
Product offeringCore offering
Catalyst Health Ventures is a Boston-based venture capital firm that invests in early-stage medical device companies developing disruptive solutions for unmet healthcare needs. The firm manages $225 million in capital under management, evaluates 600-800 companies annually, and provides investment capital, strategic guidance, and operational support to portfolio companies across clinical development, regulatory approval, and commercialization phases.
Product overview
Catalyst Health Ventures is a Boston-based venture capital firm that invests in early-stage medical device companies. The firm does not develop or sell its own products or services; rather, it provides investment capital, strategic expertise, and operational support to portfolio companies in the medtech sector. The firm's investment portfolio includes companies such as Rejoni (a clinical-stage women's health company developing the Juveena Hydrogel System) and Conformal Medical (a company developing a device to reduce stroke risk in atrial fibrillation patients).
Differentiator
Problem solved
Functional benefit
Companies that use Catalyst Health Ventures
Customer profileSegments1 record
Ideal customer profiles1 record
Catalyst Health Ventures technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Catalyst Health Ventures partnerships and signals
Strategic signalScale indicators4 records
Recent moves4 records
Expansion highlights3 records
Catalyst Health Ventures competitors and assessment
Company assessmentPeers
Broad incumbents
- OrbiMed: One of the largest healthcare-dedicated investment firms globally, with multi-strategy funds spanning venture, growth, and public equities. Directly comparable as a sector-focused healthcare VC, though materially larger in AUM and scope than Catalyst.
- Polaris Partners: Multi-stage venture firm with a long-standing life sciences practice covering therapeutics and medical devices. Comparable in medtech investing activity, though broader (digital, tech) than Catalyst's pure medtech focus.
Direct peers
- Sanderling Ventures: Early-stage medical technology venture firm based in the US, investing across therapeutic devices and biomedical platforms. Closely comparable in stage focus (early-stage medtech) and check size profile to Catalyst Health Ventures.
- Longitude Capital: Healthcare-focused venture and growth equity firm investing in medical devices, biopharmaceuticals, and healthcare services. Comparable as a healthcare-specialist VC with overlapping medtech investment thesis and US-based presence.
- HealthQuest Capital: Healthcare-dedicated growth and venture capital firm focused on commercial-stage medical devices, healthcare services, and digital health. Comparable in healthcare specialization and medtech orientation, though slightly later-stage orientation than Catalyst.
- New Leaf Venture Partners: Healthcare-focused venture firm investing in early- and late-stage medical devices, diagnostics, and therapeutics. Comparable as a sector specialist with similar clinical-stage medtech emphasis to Catalyst.
- Vivo Capital: Healthcare-focused investment firm with venture, growth, and public equity strategies covering medical devices and life sciences. Comparable as a healthcare-dedicated VC operating at similar AUM scale.
- SV Health Investors: Healthcare-dedicated venture and growth firm (formerly SV Life Sciences) investing across medical devices, biotechnology, and digital health. Comparable as a sector-specialist VC with overlapping medtech focus and US/UK footprint.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Catalyst Health Ventures social profiles
Digital presenceCatalyst Health Ventures financial estimates
Financial estimateRevenue estimate
Valuation estimate
Catalyst Health Ventures leadership team
Management profileNumber of profiles
Profiles3 records
Catalyst Health Ventures funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Catalyst Health Ventures M&A and investment
M&A and investmentM&A
Investments50 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Catalyst Health Ventures
What does Catalyst Health Ventures do?
Catalyst Health Ventures is a Boston-based venture capital firm that invests in early-stage medical device companies developing disruptive solutions for unmet healthcare needs. The firm manages $225 million in capital under management, evaluates 600-800 companies annually, and provides investment capital, strategic guidance, and operational support to portfolio companies across clinical development, regulatory approval, and commercialization phases.
Is Catalyst Health Ventures a public or private company?
Catalyst Health Ventures is a private company. It is classified as unknown and is currently operating.
When was Catalyst Health Ventures founded?
Catalyst Health Ventures was founded in 2007. It employs 11 to 50 people.
Where is Catalyst Health Ventures based?
Catalyst Health Ventures is headquartered in Boston, United States, in the North America region.
How does Catalyst Health Ventures make money?
One revenue line is on record: investment Returns / Capital Gains.
Who are Catalyst Health Ventures's main competitors?
Deerfield Management is listed as a peer. Broad incumbents are OrbiMed and Polaris Partners. Direct peers are Sanderling Ventures, Longitude Capital, HealthQuest Capital, New Leaf Venture Partners, Vivo Capital and SV Health Investors.
Does Catalyst Health Ventures have an API?
No public API is recorded for Catalyst Health Ventures.
What industry is Catalyst Health Ventures in?
Catalyst Health Ventures's product category is Venture Capital / Healthcare Investment. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 523940 and its SIC code is 6282.